These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21818622)

  • 1. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
    Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
    Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
    Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats.
    Kong WN; Chang YZ; Wang SM; Zhai XL; Shang JX; Li LX; Duan XL
    J Gastroenterol; 2008; 43(2):136-43. PubMed ID: 18306987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
    Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.
    Robach P; Recalcati S; Girelli D; Campostrini N; Kempf T; Wollert KC; Corbella M; Santambrogio P; Perbellini L; Brasse-Lagnel C; Christensen B; Moutereau S; Lundby C; Cairo G
    Eur J Haematol; 2013 Jul; 91(1):74-84. PubMed ID: 23582009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.
    Finkenstedt A; Widschwendter A; Brasse-Lagnel CG; Theurl I; Hubalek M; Dieplinger H; Tselepis C; Ward DG; Vogel W; Zoller H
    Blood Cells Mol Dis; 2012 Apr; 48(4):233-7. PubMed ID: 22365732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin as a potential biomarker for blood doping.
    Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
    Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.
    Eleftheriadis T; Pissas G; Remoundou M; Filippidis G; Antoniadi G; Oustampasidou N; Liakopoulos V; Stefanidis I
    Int Urol Nephrol; 2014 Jan; 46(1):161-7. PubMed ID: 23860963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants.
    Berglund S; Lönnerdal B; Westrup B; Domellöf M
    Am J Clin Nutr; 2011 Dec; 94(6):1553-61. PubMed ID: 22071701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
    Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
    Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
    Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia.
    Fernandes JC; Garrido P; Ribeiro S; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Reis F; Santos-Silva A
    Biomed Res Int; 2014; 2014():421304. PubMed ID: 25580431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
    Zaritsky J; Young B; Gales B; Wang HJ; Rastogi A; Westerman M; Nemeth E; Ganz T; Salusky IB
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1010-4. PubMed ID: 20299375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.
    Ashby DR; Gale DP; Busbridge M; Murphy KG; Duncan ND; Cairns TD; Taube DH; Bloom SR; Tam FW; Chapman R; Maxwell PH; Choi P
    Haematologica; 2010 Mar; 95(3):505-8. PubMed ID: 19833632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
    El Said HW; Abou Seif KH; Ahmed YS; Abou Elleil HA; El Said TW; Behairy MA; Mohamed MM; Ahmed FA
    Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
    Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation.
    Karl JP; Lieberman HR; Cable SJ; Williams KW; Young AJ; McClung JP
    Am J Clin Nutr; 2010 Jul; 92(1):93-100. PubMed ID: 20444958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.